Prosecution Insights
Prosecution Insights
8 pending office actions • 6 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (25%) |
| §112 only | 2 (25%) |
| Double-patenting only | 1 (12%) |
| Double-patenting + other | 2 (25%) |
| Multi-statute (no §101) | 1 (12%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHIM, DAVID M. | 1 | 57.8% | +55.9% |
| MARTIN, KEVIN STEPHEN | 1 | 75.8% | +24.5% |
| ABDALHAMEED, MANAHIL MIRGHANI ALI | 1 | 50.4% | +40.1% |
| O DELL, DAVID K | 1 | 57.7% | +36.0% |
| SZNAIDMAN, MARCOS L | 1 | 37.2% | +16.0% |
| JOHNSON, CHRISTOPHER LINDSAY | 1 | 51.7% | +77.8% |
| HERNANDEZ, JACKSON J | 1 | 50.9% | +28.8% |
| TOWNSLEY, SARA ELIZABETH | 1 | 24.9% | +48.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18031688 | COMPOSITIONS AND METHODS FOR TREATING KIT- AND PDGFRA-MEDIATED DISEASES | TOWNSLEY, SARA ELIZABETH | 49d overdue |
| 18710715 | CDK2 INHIBITORS AND METHODS OF MAKING AND USING SAME | MARTIN, KEVIN STEPHEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18031688 | COMPOSITIONS AND METHODS FOR TREATING KIT- AND PDGFRA-MEDIATED DISEASES | TOWNSLEY, SARA ELIZABETH | 49d overdue |
| 18853933 | EGFR INHIBITORS | SHIM, DAVID M. | — |
| 18710715 | CDK2 INHIBITORS AND METHODS OF MAKING AND USING SAME | MARTIN, KEVIN STEPHEN | — |
| 18578926 | MAP4K1 INHIBITORS | ABDALHAMEED, MANAHIL MIRGHANI ALI | — |
| 18572348 | HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER | O DELL, DAVID K | — |
| 18572382 | HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER | SZNAIDMAN, MARCOS L | — |
| 18549769 | SALT AND SOLID FORMS OF A KINASE INHIBITOR | JOHNSON, CHRISTOPHER LINDSAY | — |
| 18033931 | PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF | HERNANDEZ, JACKSON J | — |
| Art Unit | Apps |
|---|---|
| 1622 | 1 |
| 1621 | 1 |
| 1628 | 1 |
| 1691 | 1 |
| 1627 | 1 |
| 1629 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18853933 | EGFR INHIBITORS | SHIM, DAVID M. | — | §112 | Non-Final OA | — | Pending | Oct 03, 2024 |
| 18710715 | CDK2 INHIBITORS AND METHODS OF MAKING AND USING SAME | MARTIN, KEVIN STEPHEN | — | §102§103§112 | Non-Final OA | — | Pending | May 16, 2024 |
| 18578926 | MAP4K1 INHIBITORS | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §112 | Non-Final OA | — | Pending | Jan 12, 2024 |
| 18572348 | HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER | O DELL, DAVID K | 1621 | §103DP | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18572382 | HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER | SZNAIDMAN, MARCOS L | 1628 | §112DP | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18549769 | SALT AND SOLID FORMS OF A KINASE INHIBITOR | JOHNSON, CHRISTOPHER LINDSAY | 1691 | §103 | Non-Final OA | — | Pending | Sep 08, 2023 |
| 18033931 | PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF | HERNANDEZ, JACKSON J | 1627 | DP | Non-Final OA | — | Pending | Apr 26, 2023 |
| 18031688 | COMPOSITIONS AND METHODS FOR TREATING KIT- AND PDGFRA-MEDIATED DISEASES | TOWNSLEY, SARA ELIZABETH | 1629 | §103 | Final Rejection | 49d overdue | Pending | Apr 13, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial